These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27882096)

  • 61. Uncoupling protein 2 gene polymorphisms in association with overweight and obesity susceptibility: A meta-analysis.
    Zhang M; Wang M; Zhao ZT
    Meta Gene; 2014 Dec; 2():143-59. PubMed ID: 25606398
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.
    Ji W; Xu L; Zhou H; Wang S; Fang Y
    Int J Clin Exp Med; 2015; 8(10):18235-44. PubMed ID: 26770425
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monitoring clusterin and fibrillar structures in aging and dementia.
    Trindade D; Cachide M; Soares Martins T; Guedes S; Rosa IM; da Cruz E Silva OAB; Henriques AG
    Aging Brain; 2023; 3():100080. PubMed ID: 37346145
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bidirectional relationship between late-onset epilepsy (LOE) and dementia: A systematic review and meta-analysis of cohort studies.
    Tan Z; Wang FY; Wu WP; Yu LZ; Wu JC; Wang L
    Epilepsy Behav; 2024 Apr; 153():109723. PubMed ID: 38490119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CLU genetic variants and cognitive decline among elderly and oldest old.
    Mengel-From J; Thinggaard M; Lindahl-Jacobsen R; McGue M; Christensen K; Christiansen L
    PLoS One; 2013; 8(11):e79105. PubMed ID: 24244428
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The combined risk effect among BIN1, CLU, and APOE genes in Alzheimer's disease.
    Santos LRD; Almeida JFF; Pimassoni LHS; Morelato RL; Paula F
    Genet Mol Biol; 2020; 43(1):e20180320. PubMed ID: 31469155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetics of clusterin isoform expression and Alzheimer's disease risk.
    Ling IF; Bhongsatiern J; Simpson JF; Fardo DW; Estus S
    PLoS One; 2012; 7(4):e33923. PubMed ID: 22506010
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta-analysis based on latest evidence.
    Wang L; Tan Z; Wang FY; Wu WP; Wu JC
    Brain Behav; 2023 Oct; 13(10):e3207. PubMed ID: 37667521
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association between ZFHX3 and PRRX1 Polymorphisms and Atrial Fibrillation Susceptibility from Meta-Analysis.
    Wu L; Chu M; Zhuang W
    Int J Hypertens; 2021; 2021():9423576. PubMed ID: 34950514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association between
    Shim SY; Yoon HY; Yee J; Han JM; Gwak HS
    J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575660
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TREM2 R47H variant and risk for Alzheimer's disease: assessment in a Greek population and updated meta-analysis.
    Rikos D; Siokas V; Mentis AA; Aloizou AM; Liampas I; Tsouris Z; Peristeri E; Stamati P; Hadjigeorgiou GM; Dardiotis E
    Int J Neurosci; 2022 Dec; ():1-9. PubMed ID: 36408688
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Deregulated Clusterin as a Marker of Bone Fragility: New Insights into the Pathophysiology of Osteoporosis.
    Visconti VV; Greggi C; Cariati I; Gasperini B; Mastrogregori A; Botta A; Tarantino U
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456459
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An updated analysis of the association between CD2-associated protein gene rs9349407 polymorphism and Alzheimer's disease in Chinese population.
    Gao S; Hao JW; Zhao YN; Li X; Wang T; Han ZF; Sun BL; Sun JY; Liu GY
    Front Neuroinform; 2022; 16():1006164. PubMed ID: 36338943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alzheimer's disease protective allele of
    Zhao X; Li Y; Zhang S; Sudwarts A; Zhang H; Kozlova A; Moulton MJ; Goodman LD; Pang ZP; Sanders AR; Bellen HJ; Thinakaran G; Duan J
    medRxiv; 2024 Aug; ():. PubMed ID: 39185522
    [TBL] [Abstract][Full Text] [Related]  

  • 75. N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) G1001C polymorphism and susceptibility to schizophrenia: A meta-analysis.
    Saadat M
    EXCLI J; 2010; 9():11-16. PubMed ID: 29255383
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Retraction Note to: Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.
    Uddin MS; Kabir MT; Begum MM; Islam MS; Behl T; Ashraf GM
    Neurotox Res; 2022 Aug; 40(4):1125. PubMed ID: 35587311
    [No Abstract]   [Full Text] [Related]  

  • 77. Clusterin as a therapeutic target.
    Wilson MR; Zoubeidi A
    Expert Opin Ther Targets; 2017 Feb; 21(2):201-213. PubMed ID: 27978767
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Strong Association of Lipid Metabolism Related MicroRNA Binding Sites Polymorphisms with the Risk of Late Onset Alzheimer's Disease.
    Tan L; Xing A; Zhao DL; Sun FR; Tan MS; Wan Y; Tan CC; Zhang W; Miao D; Yu JT; Tan L
    Curr Neurovasc Res; 2017; 14(1):3-10. PubMed ID: 27897113
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer's Disease in Caucasian But Not Chinese population.
    Han Z; Qu J; Zhao J; Zou X
    Sci Rep; 2018 Jul; 8(1):11062. PubMed ID: 30038359
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association between CLU gene rs11136000 polymorphism and Alzheimer's disease: an updated meta-analysis.
    Zhu R; Liu X; He Z
    Neurol Sci; 2018 Apr; 39(4):679-689. PubMed ID: 29396813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.